Advanced HIV Prevention (PrEP Chicago)

HIV Clinical Trial

Official title:

Advanced HIV Prevention (PrEP Chicago)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02896699
• Other study ID #: IRB15-1250
• Status: Completed
• Phase: N/A
• Start date: March 2016
• Est. completion date: August 2019

Study information

• Verified date: January 2024
• Source: University of Chicago
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study will evaluate the feasibility of a network intervention to train individuals to disseminate PrEP information and motivate initial PrEP interest and knowledge of PrEP in their social networks.

Description:

The specific aims of this study are:

1. To recruit 450 participants in Chicago, Illinois, and to train them as peer change agents (randomized to cross-over groups) to disseminate PrEP information and motivate PrEP interest and knowledge of PrEP in their local networks.

2. To evaluate feasibility of the program over 2 years of participant follow-up through: 1) peer change agent exit survey; 2) peer change agent booster sessions; 3) peer change agent communication with University of Chicago PrEP program social media; 4) referrals into the project and; 5) calls into the PrEP warmline.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 424
• Est. completion date: August 2019
• Est. primary completion date: August 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 39 Years

Eligibility

Inclusion Criteria:

• Lives on the South Side of Chicago, Illinois

• Born male

• Has had sex with men in the previous year

• Is an active Facebook user

• Does not have plans to leave Chicago

Exclusion Criteria:

-

Related Conditions & MeSH terms

• HIV

Intervention

Behavioral:
• PrEP Intervention Group

Other:
• Control Group

Locations

Country	Name	City	State
United States	University of Chicago Medical Center	Chicago	Illinois

Sponsors (1)

Lead Sponsor	Collaborator
University of Chicago

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Network member call into the PrEPline		2 years
Secondary	PrEP Attitudes questionnaire	Monitor the change in attitude towards PrEP (1) from baseline measure to 12-months; (2) 12-months to 24-months; and (3) baseline to 24-month.	2 years
Secondary	Peer change agent boosters sessions completed		2 years
Secondary	Number of Facebook posts with respect to PrEP and sexual health		2 years
Secondary	Number of referrals enrolled into the study		2 years